InvestorsHub Logo

ronrooster

03/23/17 10:39 AM

#38052 RE: JokersWild12 #38051

Fabulous News.Would have made sense to mention ENTB_ZANDER relationship in the news release.It will just take a little longer for investors to make the connection,when they do it will be fun.Nothing on Linda Black yet.

JokersWild12

03/23/17 5:47 PM

#38053 RE: JokersWild12 #38051

From the PR today at RGBP they are closing in on preclinical drug development, which would determine dosage safety for clinicals. 2 months as it looks to get through the LO. Want to hear where this is at with ENTB and what the timing going forward is. The new veterinarians will drive this.

Target validation (TV) ? assay development ? high-throughput screening ? hit to lead (H2L) ? lead optimization (LO) ? preclinical drug development ? clinical drug development.

These companies are all radically undervalued. Again noted in the PR that more than one large pharma company has shown interest already in RGBP. RGBP working with ChemDiv is positive to larger interest. Interest will only increase with continued positive results. $$$$.

ALL IMO. GL.

parrishilton

03/24/17 4:55 PM

#38054 RE: JokersWild12 #38051

ENTB BEEN A LOSER FOR TEN YEARS NOW TOTAL CON WORTHLESS COMPANY TTYLXOX